Archive for February, 2009

Call for chapters – Biotechnology Marketing

I am extending my “Best Practices in Biotechnology” book series with additional books in specific niches in biotechnology commercialization. This project is based on my observation that details on many of the critically important elements in biotechnology business development – including managing global operations and regulations, communication and public relations, financial management, and using marketing […]


Drug Development – Balancing National and Commercial Needs

I’ll be giving a talk at the Kogod School of Business on Tuesday February 24th on “Drug Development – Balancing National and Commercial Needs”. The basis of the talk is that countries need access to medicines, foreign currency, and tax revenues, while drug developers need profits (or else they will cease to exist). I’ll be […]


Biotechnology Certificate Program at JHU's Carey School of Business

I will be opening the Business Matters for Scientists program at Johns Hopkins Carey School of Business on March 6th 2009. My focus will be providing an extensive overview of the biotechnology industry and insights on paths to entrepreneurship and business planning considerations. In addition to laying out the fundamentals for success, I will also […]


Solving the FDA Crisis

Guest content from John Avellanet, managing director and principal of Cerulean Associates: Solving the FDA Crisis By John Avellanet, Managing Director and Principal of Cerulean Associates LLC News of the latest crisis under the FDA’s watch – salmonella contamination and the peanut plant in Georgia – has all the usual suspects calling for increased inspections […]